Alise Reicin insider trades

Open-market stock purchases and sales by Alise Reicin, Chief Executive Officer at Tectonic Therapeutic, Inc, from SEC Form 4 filings since Nov 1, 2018.

Recent trades

DateStockTradeValue
Sep 25, 2026TECX Tectonic Therapeutic, IncSold (not open market)$36.6K
Sep 3, 2026TECX Tectonic Therapeutic, IncBought (not open market)—
Jun 20, 2026TECX Tectonic Therapeutic, IncSold (not open market)$28K
Jun 16, 2026IMTX Immatics NVBought (not open market)—
Jun 4, 2026SANA Sana Biotechnology, IncBought (not open market)—
Mar 4, 2026TECX Tectonic Therapeutic, IncBought (not open market)—
Mar 4, 2026TECX Tectonic Therapeutic, IncBought (not open market)—
Feb 11, 2026TECX Tectonic Therapeutic, IncBought$52.8K
Feb 11, 2026TECX Tectonic Therapeutic, IncBought$52.8K
Feb 4, 2026TECX Tectonic Therapeutic, IncSold (not open market)$95.3K
Dec 31, 2025TECX Tectonic Therapeutic, IncBought (not open market)$26.1K

Companies traded

  • TECX Tectonic Therapeutic, Inc: 2 buys, last Sep 25, 2026
  • IMTX Immatics NV: other filings, last Jun 16, 2026
  • SANA Sana Biotechnology, Inc: other filings, last Jun 4, 2026
  • FIXX Homology Medicines, Inc: other filings, last Jun 14, 2023
  • CELG Celgene Corp /de/: other filings, last Nov 20, 2019

Get free alerts when Alise Reicin files a new trade →